Journal of Family and Community Medicine

ORIGINAL ARTICLE
Year
: 2020  |  Volume : 27  |  Issue : 2  |  Page : 109--113

Cherry angioma: A case–control study


Ramah I Nazer1, Rahaf H Bashihab2, Wedad H Al-Madani3, Aamir A Omair4, Mohammed I AlJasser5 
1 Department of Medicine, Division of Dermatology, College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
2 Department of Medicine, Division of Dermatology, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia
3 National Center for Evidence Based Health Practice, Saudi Health Council, Riyadh, Saudi Arabia
4 Department of Medical Education, Research Unit, College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
5 Department of Medicine, Division of Dermatology, College of Medicine, King Saud bin Abdulaziz University for Health Sciences; Department of Medicine, Division of Dermatology, Ministry of National Guard Health Affairs; Department of Medical Education, Research Unit, College of Medicine, King Saud bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia

Correspondence Address:
Dr. Mohammed I AlJasser
Division of Dermatology, King Saud Bin Abdulaziz University for Health Sciences, P.O. Box 3660, Riyadh 11481
Saudi Arabia

BACKGROUND: Cherry angiomas (CAs) are very common asymptomatic vascular skin lesions. There are only a few studies on CAs in the literature and those assessing risk factors of CAs are scarce. The aim of our study was to determine risk factors for the development of CAs. MATERIALS AND METHODS: A case–control study was conducted at a tertiary care center in Riyadh, Saudi Arabia. Patients underwent a full-body examination for CAs. Demographics and other data including medical history and medications were extracted from electronic medical records. RESULTS: A total of three hundred patients were enrolled: one hundred cases with at least five CAs and two hundred controls without CAs. Bivariate analysis identified benign prostatic hyperplasia (odds ratio [OR]: = 2.591), malignancy (OR = 2.567), tamsulosin (OR = 3.171), and clopidogrel (OR = 0.321) as statistically significant associations. After multivariate logistic regression analysis, only tamsulosin (OR = 3.475, P = 0.009) and clopidogrel (OR = 0.281, P = 0.028) were found to be independent risk factors for CAs. Malignancies tended to be more associated with CAs, but this did not reach statistical significance (P = 0.07). CONCLUSION: Tamsulosin is a possible risk factor for the development of CAs. Clopidogrel seems to have a protective role preventing the development of CAs.


How to cite this article:
Nazer RI, Bashihab RH, Al-Madani WH, Omair AA, AlJasser MI. Cherry angioma: A case–control study.J Fam Community Med 2020;27:109-113


How to cite this URL:
Nazer RI, Bashihab RH, Al-Madani WH, Omair AA, AlJasser MI. Cherry angioma: A case–control study. J Fam Community Med [serial online] 2020 [cited 2020 Aug 13 ];27:109-113
Available from: http://www.jfcmonline.com/article.asp?issn=2230-8229;year=2020;volume=27;issue=2;spage=109;epage=113;aulast=Nazer;type=0